February 21, 2014 / 5:35 PM / 3 years ago

BRIEF-Endo to pay $173 million over Lidoderm marketing

NEW YORK, Feb 21 (Reuters) - Endo Health Solutions Inc agreed to pay $173 million to U.S. state and federal authorities to resolve allegations of unlawful marketing of the drug Lidoderm, New York Attorney General Eric Schneiderman said in a statement.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below